Krebs Biochemicals & Industries Limited

NSE KREBSBIO.NS

Krebs Biochemicals & Industries Limited Free Cash Flow Yield on February 07, 2025: -2.38%

Krebs Biochemicals & Industries Limited Free Cash Flow Yield is -2.38% on February 07, 2025, a 89.11% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Krebs Biochemicals & Industries Limited 52-week high Free Cash Flow Yield is -1.87% on November 27, 2024, which is 21.43% above the current Free Cash Flow Yield.
Krebs Biochemicals & Industries Limited 52-week low Free Cash Flow Yield is -27.16% on March 28, 2024, which is -1,039.05% below the current Free Cash Flow Yield.
Krebs Biochemicals & Industries Limited average Free Cash Flow Yield for the last 52 weeks is -5.71%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: KREBSBIO.NS

Krebs Biochemicals & Industries Limited

CEO	Mr. Jitendra Rameshchandra Shah
IPO Date	Oct. 27, 2016
Location	India
Headquarters	Maas Heights
Employees	191
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care Plastics

Description

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.

Key trends

Past 5 years